Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imatinib and hyperlipidemia.
Gottardi M, Manzato E, Gherlinzoni F. Gottardi M, et al. Among authors: gherlinzoni f. N Engl J Med. 2005 Dec 22;353(25):2722-3. doi: 10.1056/NEJMc052500. N Engl J Med. 2005. PMID: 16371644 No abstract available.
Preemptive antifungal therapy among neutropenic patients.
Stefani PM, Gottardi M, Zanetti F, Tecchio C, Sartor D, Gherlinzoni F. Stefani PM, et al. Among authors: gherlinzoni f. Clin Infect Dis. 2006 May 15;42(10):1507-8; author reply 1508-9. doi: 10.1086/503681. Clin Infect Dis. 2006. PMID: 16619177 No abstract available.
What does preemptive antifungal treatment really mean?
Stefani PM, Salvadori U, Gottardi M, Rigoli R, Scotton P, Gherlinzoni F. Stefani PM, et al. Among authors: gherlinzoni f. Clin Infect Dis. 2010 Apr 15;50(8):1201-2; author reply 1202. doi: 10.1086/651470. Clin Infect Dis. 2010. PMID: 20233047 No abstract available.
Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.
Filì C, Candoni A, Zannier ME, Olivieri J, Imbergamo S, Caizzi M, Nadali G, Di Bona E, Ermacora A, Gottardi M, Facchinelli D, Ciancia R, Lazzarotto D, Dubbini MV, Festini G, Gherlinzoni F, Michieli MG, Semenzato G, Fanin R. Filì C, et al. Among authors: gherlinzoni f. Leuk Res. 2019 Jan;76:33-38. doi: 10.1016/j.leukres.2018.11.015. Epub 2018 Nov 28. Leuk Res. 2019. PMID: 30529681
Flai (fludarabine, cytarabine, idarubicin) plus low-dose Gemtuzumab Ozogamicin as induction therapy in CD33-positive AML: Final results and long term outcome of a phase II multicenter clinical trial.
Candoni A, Papayannidis C, Martinelli G, Simeone E, Gottardi M, Iacobucci I, Gherlinzoni F, Visani G, Baccarani M, Fanin R. Candoni A, et al. Among authors: gherlinzoni f. Am J Hematol. 2018 May;93(5):655-663. doi: 10.1002/ajh.25057. Epub 2018 Mar 2. Am J Hematol. 2018. PMID: 29396857 Free article. Clinical Trial.
Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.
Piccin A, Steurer M, Mitterer M, Blöchl EM, Marcheselli L, Pusceddu I, Marabese A, Bertozzi I, Corvetta D, Randi ML, Elli E, Pogliani EM, Veneri D, Perbellini O, Krampera M, Pacquola E, Gottardi M, Tiribelli M, Guella A, Innella B, Vivaldi P, De Biasi E, Sancetta R, Rocconi R, Bassan R, Gherlinzoni F, Pizzolo G, Gastl G, Cortelazzo S. Piccin A, et al. Among authors: gherlinzoni f. Intern Emerg Med. 2015 Jun;10(4):451-60. doi: 10.1007/s11739-015-1186-8. Epub 2015 Jan 14. Intern Emerg Med. 2015. PMID: 25585678
249 results